Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2081 of 6351
-
Mass deworming experiment aims to wipe out parasitic worms in three countries
Disease control CompletedOver 1.5 billion people are infected with soil-transmitted helminths (STH). Global STH guidelines recommend MDA (mass drug administration) of albendazole or mebendazole to targeted populations, including pre-school age children and school-age children. However mathematical models…
Phase 3 • Sponsor: University of Washington • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Immunotherapy combo shows promise against rare sarcomas before surgery
Disease control OngoingThis phase II trial studies how well nivolumab with and without ipilimumab and radiation therapy when given before surgery works in treating patients with undifferentiated pleomorphic sarcoma or dedifferentiated liposarcoma that can be removed by surgery. Immunotherapy with monoc…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New combo therapy shows promise for tough pancreatic cancer
Disease control CompletedThe purpose of this study is to determine the effectiveness of combining immune therapy, pembrolizumab, with a hypomethylating agent, azacitidine, for pancreatic cancer. People who have advanced pancreatic cancer with disease progression on first-line therapy are usually treated …
Phase 2 • Sponsor: Susan E. Bates • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
3D-Printed heart models could make stroke prevention safer
Disease control CompletedAtrial fibrillation is the most common cardiac arrhythmia, affecting 8.5% of the general population in Hong Kong. Systemic embolization, and particularly stroke, is the most frequent major complication of atrial fibrillation. Long-term oral anticoagulation is recommended for most…
Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New study tests if MRI-Guided biopsy spots aggressive prostate cancer better than standard method
Diagnosis OngoingThis randomized phase II trial studies how well systematic random biopsy or magnetic resonance imaging (MRI)-ultrasound image (US) fusion biopsy work in diagnosing prostate cancer in patients with elevated prostate specific antigen. Systematic random biopsy and MRI-US fusion biop…
Sponsor: University of Southern California • Aim: Diagnosis
Last updated Jun 27, 2026 13:02 UTC
-
New hope for kids with Drug-Resistant TB: bedaquiline studied in children
Disease control CompletedP1108 was a Phase I/II, open-label, single-arm, exposure-controlled dose finding study of BDQ in infants, children, and adolescents living with and without HIV, with clinically diagnosed or bacteriologically confirmed rifampin-resistant tuberculosis (RR-TB). The study was designe…
Phase 1/2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
A new approach to help homeless youth kick the habit?
Knowledge-focused Stopped earlyThis trial develops a contextually tailored and optimized smoking cessation intervention and studies smoking motivations and motivations to quit smoking in homeless youth. Identifying motivations for smoking and motivations to quit smoking may help researchers build a program to …
Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Aug 22, 2026 00:00 UTC
-
New hope for Tough-to-Treat myeloma? early trial tests cevostamab
Disease control CompletedThis is a phase I, multicenter, open-label, dose-escalation study of cevostamab administered as a single agent by IV infusion to participants with relapsed or refractory multiple myeloma (R/R MM).
Phase 1 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Could hepatitis c positive lungs save lives? pilot study explores new transplant option
Disease control OngoingIn this study HCV negative recipients will be transplanted with HCV positive lungs. Investigators will attempt to decrease infectivity rates by performing Normothermic Ex vivo Lung Perfusion (EVLP), which is an approved method of donor lung preservation, assessment and treatment,…
Early phase 1 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Could a needle biopsy replace surgery for some breast cancer patients?
Diagnosis OngoingThe purpose of this study is to test the ability of a breast MRI biopsy to accurately diagnose a complete tumor response to the neoadjuvant chemotherapy (NAC) that the patient just finished. Numerous studies have shown that MRI has the highest accuracy for diagnosing a complete t…
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Diagnosis
Last updated Jun 27, 2026 07:54 UTC
-
Virus therapy targets Hard-to-Treat endometrial cancer
Disease control OngoingThis phase I trial studies the side effects and best dose of vesicular stomatitis virus-human interferon beta-sodium iodide symporter (VSV-hIFNbeta-NIS) with or without ruxolitinib phosphate in treating patients with stage IV endometrial cancer or endometrial cancer that has come…
Phase 1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
New surgery could give amputees 'Bionic' control over prosthetic legs
Disease control CompletedThe hypothesis of this research protocol is that we will be able to redesign the manner in which lower limb amputations are performed so as to include biological actuators that will enable the successful employment of next generation lower extremity prostheses. The specific aims …
Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Freezing prostate tumors shows promise in 354-Patient study
Disease control CompletedThis is a prospective data collection of men who are electing to undergo prostate hemi-gland cryoablation. The purpose of this observational research study is to investigate the localized treatment of prostate cancer using hemi-gland cryoablation. UCLA patients undergoing hemi-…
Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New drug cocktail targets Hard-to-Treat lung cancer
Disease control OngoingThis research study is studying a drug combination as a possible treatment for anaplastic lymphoma kinase-positive (ALK+) non-small cell lung cancer. The drugs involved in this study are: * Alectinib * Cobimetinib
Phase 1/2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Immunotherapy-Chemo cocktail shows promise in tough breast cancer
Disease control CompletedThe purpose of the study is to evaluate the impact on progression-free survival (PFS) with the combination carboplatin - pembrolizumab in patients with CTC (circulating tumor cells) positive, HER2 negative metastatic breast cancer previously treated with anthracyclines and taxane…
Phase 2 • Sponsor: Northwestern University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug duo takes on rare sarcomas
Disease control OngoingThe purpose of this study is to test any good and bad effects of the combination of study drugs called NKTR-214 and nivolumab.
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Knee injection shows promise for regrowing cartilage in osteoarthritis
Disease control CompletedThe purpose of this two-part study is to assess the efficacy, safety and tolerability of multiple intra-articular (i.a.) injections of LNA043, in regenerating the articular surface in patients with cartilage lesions of the knee (Part A) and knee osteoarthritis (Part B).
Phase 2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Blood cancer transplant study tests safer GVHD prevention
Disease control Stopped earlyThis randomized phase II trial includes a blood stem cell transplant from an unrelated donor to treat blood cancer. The treatment also includes chemotherapy drugs, but in lower doses than conventional (standard) stem cell transplants. The researchers will compare two different dr…
Phase 2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Immunotherapy and PARP inhibitor combo tested in Hard-to-Treat breast cancer
Disease control CompletedThis trial will evaluate the use of immunotherapy and PARP inhibition in a population with incurable advanced breast cancer associated with a germline BRCA mutation or HDR-defect. The main objective is to examine overall response rate of pembrolizumab (immunotherapy) in combinati…
Phase 2 • Sponsor: Yuan Yuan • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Massive study seeks to unlock secrets of sudden cardiac arrest
Knowledge-focused OngoingIdentification of Causes and Risk Factors for Out-of-Hospital Cardiac Arrest through Development of Prediction Model and Novel Biomarkers Study Objectives: 1. To identify causes and risk factors of OHCA incidence that are associated with chronic diseases and health behaviors 2.…
Sponsor: Seoul National University Hospital • Aim: Knowledge-focused
Last updated Aug 07, 2026 00:00 UTC